January 6, 2017
Shield’s iron deficiency anaemia drug kicks off well in Europe
Shield Therapeutics said it was encouraged by the the demand of its its recently approved product for the treatment of iron…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 6, 2017
GHG wraps up ABC Pharmacy buy
Georgia Healthcare Group (GHG) has finished all the paperwork in connection with buying the fourth largest pharmaceutical retailer in Georgia, ABC Pharmacia (ABC).
January 6, 2017
INEOS Styrolution presents new materials at Pharmapack 2017
INEOS Styrolution, the global leader in styrenics, will present new product highlights and a range of new applications for the healthcare industry at Pharmapack 2017 in Paris (Paris Expo, Porte de Versailles).
January 5, 2017
Lilly mixes managers, reduces U.S. staff due to Solanezumab test fail
Eli Lilly begins new year with reorganizing its leadership structure to pursue better growth opportunities in the upcoming years. The Chief Executive Officer of Lilly, David A. Ricks, who’s new position is also one among the latest promotions, said that the changes made to pharmaceutical therapeutics and geographic business should simplify and maximize the company’s late-stage pipeline and new drugs, as well as to improve productivity.
January 5, 2017
Ceylad kicks off THINK cancer trial in Belgium, blood taken from the first patient
Celyad has started on Thursday its Therapeutic Immunotherapy with NKR-2 (THINK) trial in Belgium with the first patient giving blood.
To remind, THINK trial is an open-label Phase Ib study to assess the safety and clinical activity of multiple administrations of autologous CAR-T NKR-2 cells in seven refractory cancers.
January 5, 2017
OptiBiotix replaces Commercial Director
OptiBiotix Health is rearranging its directorial staff as it has changed its Commercial Director. Namely, Jim Laird will be substituted by Per Rehné to that directorial position.
January 5, 2017
Nicox provides clinical and regulatory update for NCX 4251 in blepharitis
Nicox has provided certain regulatory and clinical updates for NCX 4251, its novel ophthalmic suspension of fluticasone propionate nanocrystals being…
January 5, 2017
Neovacs and Professor Robert Kerbel together fight cancer
Neovacs and Professor Robert Kerbel and his team at the Sunnybrook Research Institute of Toronto, Canada are about to join…
January 4, 2017
Sanofi enters New Year with new deal, ends its vaccine joint venture
Sanofi has starts new year with big changes. In two separate statements the company announced closing a deal and ending a joint venture.
December 30, 2016
Corporate makeovers drive corporate takeovers in 2016 M&A bonanza
In 2016, mega deals became ever more transformative.
German drug and crop chemical maker Bayer AG announced its $66 billion takeover of U.S. agrochemicals company Monsanto Co, while ChemChina signed a $43 billion acquisition of Swiss seeds group Syngenta AG, as consolidation in the sector intensified.